Organometallics
Article
12.2 Hz, 1H, CH), 3.01 (m, 1H, CHH), 2.74 (dd, J = 6.0 and 14.2 Hz,
1H, CHH). 13C{1H} NMR (100 MHz, benzene-d6): δ 145.8, 136.7,
131.9, 121.9, 120.0, 118.3 (aromatic C), 116.1, 115.1 (C5H5), 92.2,
87.9 (cage C), 63.6 (CH), 41.8 (CH2). 11B{1H} NMR (96 MHz,
benzene-d6): δ −0.3 (1B), −5.0 (3B), −7.0 (3B), −10.2 (3B). IR
(KBr, cm−1): ν 2568 (BH). Anal. Calcd for C20H27B10ClZr (3f): C,
47.83; H, 5.42. Found: C, 48.07; H, 5.68.
Preparation of 1,2-[Cp2ZrCH(4-Cl-C6H4)CH2]-1,2-C2B10H10
(3g). This complex was prepared as purple crystals from 1 (554 mg,
1.0 mmol) and 4-chlorostyrene (2g; 277 mg, 2.0 mmol) using the
same procedures reported for 3b: yield 430 mg (86%). 1H NMR (400
MHz, benzene-d6): δ 6.99 (d, J = 8.4 Hz, 2H), 5.78 (d, J = 8.4 Hz, 2H)
(aromatic H), 5.74 (s, 5H), 5.16 (s, 5H) (C5H5), 3.58 (dd, J = 6.4,
12.8 Hz, 1H, CH), 3.01 (m, 1H, CHH), 2.72 (dd, J = 6.4, 14.4 Hz, 1H,
CHH). 13C{1H} NMR (100 MHz, benzene-d6): δ 142.9, 129.8, 127.4,
123.4 (aromatic C), 116.6, 115.5 (C5H5), 91.2, 86.6 (cage C), 62.6
(CH), 42.4 (CH2). 11B{1H} NMR (96 MHz, benzene-d6): δ 0.27 (1B),
−5.0 (2B), −6.6 (3B), −10.3 (4B). IR (KBr, cm−1): ν 2574 (BH).
Anal. Calcd for C20H27B10ClZr (3g): C, 47.83; H, 5.42. Found: C,
48.23; H, 5.11.
Figure 6. Molecular structure of 1,2-[Cp2ZrCH2CH(CH2PPh2)]-1,2-
C2B10H10 (4r).
Preparation of 1,2-[Cp2ZrCH(3-CF3-C6H4)CH2]-1,2-C2B10H10
(3i). This complex was prepared as a pale white solid from 1 (554
mg, 1.0 mmol) and 3-trifluoromethylstyrene (2i; 344 mg, 2.0 mmol)
11B{1H} NMR (96 MHz, benzene-d6): δ 0.66 (1B), −4.0 (1B), −5.6
(5B), −8.7 (3B). IR (KBr, cm−1): ν 2567 (BH). Anal. Calcd for
C21H30B10Zr (3b): C, 52.35; H, 6.28. Found: C, 52.53; H, 6.44.
Preparation of 1,2-[Cp2ZrCH(4-MeO-C6H4)CH2]-1,2-C2B10H10
(3c). This complex was prepared as a purple solid from 1 (554 mg, 1.0
mmol) and 4-methoxystyrene (2c; 270 mg, 2.0 mmol) using the same
procedures reported for 3b: yield 387 mg (78%). 1H NMR (400 MHz,
pyridine-d5): δ 7.09 (d, J = 8.4 Hz, 2H, aromatic H), 6.54 (m, 7H,
aromatic H and C5H5), 5.64 (s, 5H, C5H5), 3.71 (s, 3H, OCH3), 3.55
(m, 2H, CH and CHH), 3.09 (dd, J = 5.6, 13.2 Hz, 1H, CHH).
13C{1H} NMR (100 MHz, pyridine-d5): δ 156.2, 131.8, 119.8, 116.8,
1
using the same procedures reported for 3b: yield 490 mg (91%). H
NMR (400 MHz, benzene-d6): δ 6.89 (m, 2H), 6.25 (s, 1H), 6.24(d, J
= 8.8 Hz, 1H) (aromatic H), 5.79 (s, 5H), 5.16 (s, 5H) (C5H5), 3.67
(dd, J = 6.0, 12.6 Hz, 1H, CH), 3.13 (m, 1H, CHH), 2.73 (dd, J = 6.0,
14.2 Hz, 1H, CHH). 13C{1H} NMR (75 MHz, benzene-d6): δ 146.0,
130.4, 129.3, 126.1, 118.2 (aromatic C), 116.8, 115.9 (C5H5), 90.8,
86.0 (cage C), 61.9 (CH), 42.2 (CH2). 11B{1H} NMR (96 MHz,
benzene-d6): δ 0.7 (1B), −2.0 (1B), −4.8 (2B), −6.4 (3B), −8.7 (1B),
−10.1 (2B). IR (KBr, cm−1): ν 2566 (BH). Anal. Calcd for
C24.5H31B10F3Zr (3i + 0.5 toluene): C, 50.58; H, 5.37. Found: C,
50.52; H, 5.43.
112.2 (aromatic C), 114.9, 113.8 (C5H5), 95.3, 91.1 (cage C), 66.0
(CH), 54.7 (OCH3), 41.3 (CH2). 11B{1H} NMR (96 MHz, pyridine-
d5): δ −1.2 (1B), −5.3 (1B), −6.2 (2B), −7.2 (2B), −9.9 (4B). IR
(KBr, cm−1): ν 2562 (BH). Anal. Calcd for C21H30B10OZr (3c): C,
50.67; H, 6.07. Found: C, 50.39; H, 6.01.
Preparation of 1,2-[Cp2ZrCH(4-CF3-C6H4)CH2]-1,2-C2B10H10
(3j). This complex was prepared as a pale white solid from 1 (554
mg, 1.0 mmol) and 4-trifluoromethylstyrene (2j; 344 mg, 2.0 mmol)
1
using the same procedures reported for 3b: yield 391 mg (73%). H
Preparation of 1,2-[Cp2ZrCH(4-tBuO-C6H4)CH2]-1,2-C2B10H10
(3d). This complex was prepared as red crystals from 1 (554 mg, 1.0
mmol) and 4-tert-butoxystyrene (2d; 352 mg, 2.0 mmol) using the
same procedures reported for 3b: yield 362 mg (67%). 1H NMR (400
MHz, benzene-d6): δ 6.80 (d, J = 8.4 Hz, 2H, aromatic H), 5.73 (m,
7H, aromatic H and C5H5), 4.99 (s, 5H, C5H5), 3.28 (dd, J = 6.4, 12.0
Hz, 1H, CH), 3.07 (m, 1H, CHH), 2.93 (dd, J = 6.4, 14.0 Hz, 1H,
CHH), 1.24 (s, 9H, C(CH3)3). 13C{1H} NMR (100 MHz, benzene-
d6): δ 150.8, 134.9, 128.3, 126.0, 124.6, 118.9 (aromatic C), 114.3,
113.1 (C5H5), 93.0, 89.1 (cage C), 77.2 (OC(CH3)3), 64.8 (CH), 41.1
(CH2), 27.9 (OC(CH3)3). 11B{1H} NMR (96 MHz, benzene-d6): δ
0.2 (1B), −4.2 (2B), −5.0 (1B), −6.2 (2B), −9.3 (4B). IR (KBr,
cm−1): ν 2571 (BH). Anal. Calcd for C24H36B10OZr (3d): C, 53.39; H,
6.72. Found: C, 53.51; H, 6.65.
NMR (400 MHz, benzene-d6): δ 7.26 (d, J = 8.0 Hz, 2H), 5.93 (d, J =
8.0 Hz, 2H) (aromatic H), 5.75 (s, 5H), 5.15 (s, 5H) (C5H5), 3.76
(dd, J = 5.6, 12.4 Hz, 1H, CH), 3.11 (m, 1H, CHH), 2.71 (dd, J = 5.6,
14.0 Hz, 1H, CHH). 13C{1H} NMR (100 MHz, benzene-d6): δ 149.3,
129.3, 126.4, 122.3 (aromatic C), 116.9, 116.0 (C5H5), 90.6, 85.8 (cage
C), 62.2 (CH), 42.1 (CH2). 11B{1H} NMR (96 MHz, benzene-d6): δ
0.6 (1B), −4.7 (3B), −6.4 (3B), −8.8 (1B), −10.1 (2B). IR (KBr,
cm−1): ν 2573 (BH). Anal. Calcd for C21H27B10F3Zr (3j): C, 47.08; H,
5.08. Found: C, 46.72; H, 4.94.
Preparation of 1,2-[Cp2ZrCH(4-Br-C6H4)CH2]-1,2-C2B10H10
(3k). This complex was prepared as purple crystals from 1 (554 mg,
1.0 mmol) and 4-bromostyrene (2k; 366 mg, 2.0 mmol) using the
same procedures reported for 3b: yield 364 mg (82%). 1H NMR (400
MHz, pyridine-d5): δ 7.47 (d, J = 8.4 Hz, 2H), 6.66 (d, J = 8.4 Hz, 2H)
(aromatic H), 6.71 (s, 5H), 6.00 (s, 5H) (C5H5), 4.10 (dd, J = 6.0,
12.6 Hz, 1H, CH), 3.68 (m, 1H, CHH), 2.96 (dd, J = 6.0, 14.2 Hz, 1H,
CHH). 13C{1H} NMR (100 MHz, pyridine-d5): δ 143.1, 132.4, 123.6,
114.4 (aromatic C), 116.8, 115.9 (C5H5), 91.6, 86.9 (cage C), 62.2
(CH), 41.7 (CH2). 11B{1H} NMR (96 MHz, pyridine-d5): δ −0.6
(2B), −2.5 (1B), −5.5 (4B), −9.2 (3B). IR (KBr, cm−1): ν 2571 (BH).
Anal. Calcd for C20H27B10BrZr (3k): C, 43.94; H, 4.98. Found: C,
44.20; H, 5.10.
Preparation of 1,2-[Cp2ZrCH(4-F-C6H4)CH2]-1,2-C2B10H10 (3l).
This complex was prepared as purple crystals from 1 (554 mg, 1.0
mmol) and 4-fluorostyrene (2l; 244 mg, 2.0 mmol) using the same
procedures reported for 3b: yield 393 mg (81%). 1H NMR (400 MHz,
benzene-d6): δ 6.69 (t, J = 8.4 Hz, 2H), 5.81 (dd, J = 5.2, 8.4 Hz, 2H)
(aromatic H), 5.75 (s, 5H), 5.17 (s, 5H) (C5H5), 3.60 (dd, J = 6.4,
12.6 Hz, 1H, CH), 3.04 (m, 1H, CHH), 2.76 (dd, J = 6.4, 14.2 Hz, 1H,
CHH). 13C{1H} NMR (75 MHz, benzene-d6): δ 140.3, 123.5 (J = 6.8
Hz), 116.4, 115.5 (aromatic C), 116.5, 115.5 (C5H5), 86.7 (cage C),
62.5 (CH), 42.8 (CH2). 11B{1H} NMR (128 MHz, benzene-d6): δ 0.4
Preparation of 1,2-[Cp2ZrCH(2-Cl-C6H4)CH2]-1,2-C2B10H10
(3e). This complex was prepared as purple crystals from 1 (554 mg,
1.0 mmol) and 2-chlorostyrene (2e; 277 mg, 2.0 mmol) using the
same procedures reported for 3b: yield 378 mg (75%). 1H NMR (400
MHz, benzene-d6): δ 7.05 (d, J = 8.0 Hz, 1H), 6.95 (m, 2H), 6.54 (m,
1H) (aromatic H), 5.99 (s, 5H), 5.53 (s, 5H) (C5H5), 3.83 (m, 1H,
CH), 3.02 (dd, J = 9.4, 15.0 Hz, 1H, CHH), 2.84 (dd, J = 7.6, 15.0 Hz,
1H, CHH). 13C{1H} NMR (75 MHz, benzene-d6): δ 149.2, 129.9,
129.1, 127.3, 126.0, 123.2 (aromatic C), 117.6, 116.7 (C5H5), 88.8,
84.5 (cage C), 58.0 (CH), 44.4 (CH2). 11B{1H} NMR (96 MHz,
benzene-d6): δ 0.45 (1B), −5.4 (2B), −6.4 (3B), −7.8 (2B), −9.6
(2B). IR (KBr, cm−1): ν 2566 (BH). Anal. Calcd for C21.75H29B10ClZr
(3e + 0.25 toluene): C, 49.74; H, 5.57. Found: C, 49.85; H, 5.64.
Preparation of 1,2-[Cp2ZrCH(3-Cl-C6H4)CH2]-1,2-C2B10H10
(3f). This complex was prepared as purple crystals from 1 (554 mg,
1.0 mmol) and 3-chlorostyrene (2f; 277 mg, 2.0 mmol) using the same
procedures reported for 3b: yield 440 mg (84%). 1H NMR (400 MHz,
benzene-d6): δ 6.71 (m, 2H), 5.95 (s, 1H), 5.86 (d, J = 7.6 Hz, 1H)
(aromatic H), 5.78 (s, 5H), 5.12 (s, 5H) (C5H5), 3.42 (dd, J = 6.0,
4439
dx.doi.org/10.1021/om300202p | Organometallics 2012, 31, 4435−4441